Penn's Gene Therapy Startup Raises Another $50 Million
Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.
Read moreNational Blood Foundation Early-Career Grant for Dr. Vijay Bhoj
Award for research in the fields of transfusion medicine and cellular therapies.
Read moreChimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma: Additional data shows remissions past two years among patients treated in earlier pilot study.
Read moreCancer Immunotherapy Research
20 years of Penn Medicine's "ImmunoRevolution" that has created personalized immunotherapy treatments to reprogram the immune system to recognize and kill cancer cells.
Read moreDr. Bruce Levine Appointed as Deputy Director of Technology Innovation at CCI
New role to coordinate the assessment and integration of new technologies into the continuum of new cellular therapies at the Center for Cellular Immunotherapies (CCI).
Read moreFDA Approves Personalized Cellular Therapy for Advanced Leukemia
Landmark decision for the field of cancer immunotherapy for first therapy based on gene transfer approved by the FDA.
Read more
